Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ewing, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

SEC filing history

Showing 176-200 of 688 matching filings.

Per page
25
Current page
8
8-K File 001-32302

8-K

Filing date
27 Jan 2020
Reporting date
27 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jan 2020
Reporting date
10 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K INVESTOR PRESENTATION

Filing date
13 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Dec 2019
Reporting date
23 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Dec 2019
Reporting date
09 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Dec 2019
Reporting date
09 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Dec 2019
Reporting date
09 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Nov 2019
Reporting date
11 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Nov 2019
Reporting date
11 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K

Filing date
05 Nov 2019
Reporting date
05 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Nov 2019
Reporting date
01 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Nov 2019
Reporting date
31 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K INVESTOR PRESENTATION SLIDES

Filing date
10 Sep 2019
Reporting date
10 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K

Filing date
06 Aug 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-232775

S-8

Filing date
23 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K ITEM 1.01 LEASE

Filing date
05 Jul 2019
Reporting date
01 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K

Filing date
27 Jun 2019
Reporting date
26 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K ITEM 5.07

Filing date
18 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K INVESTOR PRESENTATION

Filing date
18 Jun 2019
Reporting date
18 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .